The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 06, 2018
Filed:
May. 27, 2016
Applicant:
Agenovir Corporation, South San Francisco, CA (US);
Inventors:
Stephen R. Quake, Stanford, CA (US);
Jianbin Wang, South San Francisco, CA (US);
Assignee:
Agenovir Corporation, South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); C12N 9/16 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); C12N 9/22 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/52 (2006.01); C12N 15/67 (2006.01); A61K 39/12 (2006.01); A61K 48/00 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 31/04 (2006.01); C07K 14/005 (2006.01); C07K 14/195 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0014 (2013.01); A61K 9/08 (2013.01); C12N 9/16 (2013.01); C12Y 301/00 (2013.01);
Abstract
Herpes simplex virus (HSV) including herpes simplex virus 1 and 2 (HSV-1 and HSV-2) are a persistent cause of human disease with no known cure. Guided nuclease systems target specific regions of the HSV-1 and HSV-2 genomes, disrupting the virus' nucleic acid and rendering even latent viruses incapacitated.